Request for four (4) QuantStudio 5 real-time PCR systems (one for MOD1, one for

The contract involves the purchase of four QuantStudio 5 real-time PCR systems, each designed for high precision and ease of use. These systems come factory-calibrated to enable quick installation and require minimal calibration for ongoing maintenance. Each unit is equipped with a full-function touchscreen, supports 96-well (0.2ml or 0.1ml) and 384-well consumables, and includes multiplexing capabilities for up to six targets. Notably, the Applied Biosystems 96-well blocks incorporate VeriFlex technology, which features six independent temperature zones to ensure precise thermal control for optimized performance. The systems also support remote monitoring, optional cloud-based analysis and data sharing, and software compliant with 21 CFR Part 11, making them suitable for regulated laboratory environments. These four instruments will be acquired as part of ORTS' bundle purchase through the Food and Drug Administration, under a forecast solicitation dated March 2026. While specific location details and contracting officers have yet to be determined, the procurement falls under the NAICS code 541990, indicating scientific research and development services. The point of contact for the program acquisition is available via email for further inquiries. This acquisition will enhance the FDA’s laboratory capabilities with advanced, compact real-time PCR systems optimized for sensitivity, flexibility, and compliance.